Abstract
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD), considered a metabolic syndrome, is characterized by the accumulation of fat in the form of triglycerides in the liver. It represents the main cause for the development of severe liver diseases, such as cirrhosis and hepatocellular carcinoma (HCC), due to the formation of the inflammatory microenvironment and …